ProKidney Corp. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() ACLX
Arcellx, Inc. |
$75.01 | $2.72 B | -49.3 | 163 | $107.94 M |
![]() ARVN
Arvinas, Inc. |
$19.91 | $1.83 B | -4.41 | 430 | $263.40 M |
![]() BDTX
Black Diamond Therapeutics, Inc. |
$2.13 | $291.95 M | -3.13 | 24 | $0 |
![]() CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
![]() DICE
DICE Therapeutics, Inc. |
$47.55 | $2.27 B | -21.91 | 71 | $0 |
![]() ENOB
Enochian Biosciences, Inc. |
$0.71 | $45.38 M | -0.34 | 22 | $0 |
![]() ERAS
Erasca, Inc. |
$2.67 | $647.94 M | -2.83 | 126 | $0 |
![]() EWTX
Edgewise Therapeutics, Inc. |
$26.56 | $1.65 B | -11.47 | 110 | $0 |
![]() GLUE
Monte Rosa Therapeutics, Inc. |
$6.89 | $243.38 M | -1.59 | 133 | $0 |
![]() IMCR
Immunocore Holdings plc |
$29.87 | $2.08 B | -26.72 | 493 | $310.20 M |
![]() KURA
Kura Oncology, Inc. |
$8.51 | $1.66 B | -10.03 | 192 | $53.88 M |
![]() LYEL
Lyell Immunopharma, Inc. |
$0.68 | $619.50 M | -2.7 | 224 | $61,000 |
![]() MRUS
Merus N.V. |
$42.39 | $3.50 B | -19.38 | 260 | $36.13 M |
![]() PCVX
Vaxcyte, Inc. |
$85.99 | $7.72 B | -16.54 | 414 | $0 |
![]() PLRX
Pliant Therapeutics, Inc. |
$13.18 | $672.63 M | -3.9 | 171 | $0 |
![]() PMVP
PMV Pharmaceuticals, Inc. |
$1.57 | $85.40 M | -1.26 | 47 | $0 |
![]() PTGX
Protagonist Therapeutics, Inc. |
$38.09 | $2.04 B | 13.7 | 126 | $434.43 M |
![]() REPL
Replimune Group, Inc. |
$12.02 | $485.18 M | -2.44 | 331 | $0 |
![]() RLAY
Relay Therapeutics, Inc. |
$4.57 | $1.05 B | -3 | 261 | $10.01 M |
![]() RVMD
Revolution Medicines, Inc. |
$43.84 | $6.66 B | -10.51 | 534 | $0 |
![]() STOK
Stoke Therapeutics, Inc. |
$11.02 | $774.50 M | -6.14 | 110 | $8.78 M |
![]() THRD
Third Harmonic Bio, Inc. |
$11.17 | $581.89 M | -18.95 | 51 | $0 |
![]() VTYX
Ventyx Biosciences, Inc. |
$2.42 | $229.83 M | -1.01 | 79 | $0 |